EMBL Australia

Dr Qi Zhang will commence in December as the first EMBL Australia Group Leader to be based at the South Australian immunoGENomics Cancer Institute (SAiGENCI), Adelaide.

A study co-led by group leader Dr Senthil Arumugam and published in Nature Communications reveals a novel mechanism by which cells control the orderly & timely delivery of molecular cargo.

We’re excited to announce that Dr Qi Zhang will be the first EMBL Australia group leader to be hosted at the South Australian immunoGENomics Cancer Institute.

EMBL Australia researchers have made an exciting breakthrough in the field of regenerative medicine, offering new hope for safer and more effective treatments.

The recent EMBL Australia training event at Monash University, ‘Beyond Imaging: Visualisation, analysis & inference’, proved a hit with the local imaging community, with many keen to see the event return and expand.

PhD students Bec Degnan and Bonnie Werner share the benefits of travelling to EMBL Heidelberg with an EMBL Australia travel grant, including newfound confidence in science communication and inspiration to change research direction.

EMBL Australia and Burnet Institute group leader Dr Michelle Boyle has been awarded Australia’s largest philanthropic biomedical fellowship to support her research into malaria immunity.

Dr William Roman will begin as an EMBL Australia Group Leader, based at the Australian Regenerative Medicine Institute, Monash University, in May.

We’re excited to welcome three new members – Professor Helen Thomas, Professor Jennifer Stow and Ms Erica Kneipp – to the EMBL Australia Council, as we bid a fond farewell to Professor Andrew Sinclair and Dr David Hansen.

Farewell to Professor David Lynn and Associate Professor Ville-Petteri Mäkinen, who have successfully completed their nine-year terms as EMBL Australia group leaders.